GSK PLC

Active United Kingdom

Activities of head offices

0 employees website.com
Life sciences and medical technology Activities of head offices
G

GSK PLC

Activities of head offices

Founded 6 Dec 1999 Active United Kingdom 0 employees website.com
Life sciences and medical technology Activities of head offices

Previous Company Names

GLAXOSMITHKLINE PLC 21 Jun 2000 — 16 May 2022
GLAXO SMITHKLINE PLC 14 Jan 2000 — 21 Jun 2000
TRUSHELFCO (NO.2577) LIMITED 6 Dec 1999 — 14 Jan 2000
Accounts Due 30 Jun 2026 19 days remaining
Confirmation
Net assets £15,956M £2,870M 2025 year on year
Total assets £61,118M £1,655M 2025 year on year
Total Liabilities £45,162M £1,215M 2025 year on year
Charges None No charges registered

Contact & Details

Contact

Telephone

0800 000 0000

Website

www.example.com

Full company profile for GSK PLC (03888792), an active life sciences and medical technology company based in United Kingdom. Incorporated 6 Dec 1999. Activities of head offices. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2025
Type group
Next accounts 31 Dec 2025
Due by 30 Jun 2026 19 days remaining

Balance Sheet & P&L (2013–2025)

Cash in Bank

£3406.00M

Decreased by £485.00M (-12%)

Net Assets

£15956.00M

Increased by £2870.00M (+22%)

Total Liabilities

£45162.00M

Decreased by £1215.00M (-3%)

Turnover

£33562.00M

Increased by £1547.00M (+5%)

Employees

N/A

Debt Ratio

74%

Decreased by 4 (-5%)

Financial History

Revenue, profit, EBITDA and key financial figures

2025
31 Dec Year End
2024
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Grants 7

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

713 Allotments 9,493,129 Shares £103.46m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
29 May 2026131£1k£11.2
29 May 2026380£4k£11.27
29 May 20262,752£31k£11.39
22 May 20261,204£13k£11.2
22 May 2026380£4k£11.27

Officers

Officers

1 active 2 resigned
Status
Hal BarronDirectorAmericanUnited States631 Jan 2018Active

Shareholders

Shareholders (16)

Blackrock Finance, Inc
5.7%
Dodge & Cox
5.0%

Persons with Significant Control

Persons with Significant Control (0)

No PSC information available

Group Structure

Group Structure

GSK PLC Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
8 Jun 2026CapitalAllotment of shares (GBP 1,348,825,316.56) on 5 Jun 2026
5 Jun 2026CapitalCapital Return Purchase Own Shares Treasury Capital Date
5 Jun 2026CapitalCapital Return Purchase Own Shares Treasury Capital Date
3 Jun 2026CapitalCapital Return Purchase Own Shares Treasury Capital Date
3 Jun 2026CapitalCapital Return Purchase Own Shares Treasury Capital Date
8 Jun 2026 Capital

Allotment of shares (GBP 1,348,825,316.56) on 5 Jun 2026

5 Jun 2026 Capital

Capital Return Purchase Own Shares Treasury Capital Date

5 Jun 2026 Capital

Capital Return Purchase Own Shares Treasury Capital Date

3 Jun 2026 Capital

Capital Return Purchase Own Shares Treasury Capital Date

3 Jun 2026 Capital

Capital Return Purchase Own Shares Treasury Capital Date

Recent Activity

Latest Activity

Allotment of shares (GBP 1,348,825,316.56) on 5 Jun 2026

2 days ago on 8 Jun 2026

Capital Return Purchase Own Shares Treasury Capital Date

5 days ago on 5 Jun 2026

Capital Return Purchase Own Shares Treasury Capital Date

5 days ago on 5 Jun 2026

Capital Return Purchase Own Shares Treasury Capital Date

1 weeks ago on 3 Jun 2026

Capital Return Purchase Own Shares Treasury Capital Date

1 weeks ago on 3 Jun 2026